Author:
Stacul Fulvio,Morcos Sameh K.
Publisher
Springer Berlin Heidelberg
Reference121 articles.
1. Aguirre FV, Simoons ML, Ferguson JJ et al (1997) Impact of contrast media on clinical outcomes following percutaneous coronary interventions with platelet glycoprotein IIb/IIIa inhibition: meta-analysis of clinical trials with abciximab. Circulation 96(Suppl 1):161
2. Al Dieri R, de Muinck E, Hemker C, Beguin S (2001) An ionic contrast agent inhibits platelet-dependent thrombin generation and boots the effect of abciximab. Thromb Haemost 85:944–945
3. Al Dieri R, Beguin S, Hemker C (2003) The ionic contrast medium ioxaglate interferes with thrombin-mediated feedback activation of factor V, factor VIII and platelets. J Thromb Haemost 1:269–274
4. Albanese JR, Venditto JA, Patel GC, Ambrose JA (1995) Effects of ionic and non-ionic contrast media on in vitro and in vivo platelet activation. Am J Cardiol 76:1059–1063
5. Almén T, Aspelin P, Nilsson P (1980) Aortic and pulmonary arterial pressure after injection of contrast media into the right atrium of the rabbit. Comparison between metrizoate, ioxaglate and iohexol. Acta Radiol Suppl 362:37–41